Outcomes of Fludarabine, Melphalan and Total Body Irradiation as a Reduced Intensity Conditioning Regimen in Matched Donor Allogeneic Peripheral Blood Stem Cell Transplantation.


Journal

Transplantation and cellular therapy
ISSN: 2666-6367
Titre abrégé: Transplant Cell Ther
Pays: United States
ID NLM: 101774629

Informations de publication

Date de publication:
08 2021
Historique:
received: 15 01 2021
revised: 15 03 2021
accepted: 29 04 2021
pubmed: 16 5 2021
medline: 3 8 2021
entrez: 15 5 2021
Statut: ppublish

Résumé

Fludarabine 30 mg/m

Identifiants

pubmed: 33991722
pii: S2666-6367(21)00891-5
doi: 10.1016/j.jtct.2021.04.029
pii:
doi:

Substances chimiques

Vidarabine FA2DM6879K
fludarabine P2K93U8740
Melphalan Q41OR9510P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

665.e1-665.e7

Informations de copyright

Copyright © 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Auteurs

Dipenkumar Modi (D)

Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan; Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. Electronic address: modid@karmanos.org.

Jie Chi (J)

Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

Seongho Kim (S)

Biostatistics Core, Barbara Ann Karmanos Cancer Institute, Department of Oncology, Wayne State University, Detroit, Michigan.

Abhinav Deol (A)

Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

Lois Ayash (L)

Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

Voravit Ratanatharathorn (V)

Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

Joseph P Uberti (JP)

Department of Oncology, Blood & Marrow Stem Cell Transplant Program, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH